Laman UtamaAGIO • NASDAQ
add
Agios Pharmaceuticals Inc
$27.22
Selepas Waktu Dagangan:(0.00%)0.00
$27.22
Tutup: 31 Dis, 5:22:16 PTG GMT-5 · USD · NASDAQ · Penafian
Tutup sebelumnya
$27.33
Julat hari
$26.74 - $27.61
Julat tahun
$22.24 - $45.99
Permodalan pasaran
1.59B USD
Bilangan Purata
2.48J
Nisbah P/E
-
Hasil dividen
-
Pertukaran utama
NASDAQ
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Hasil | 12.88J | 43.69% |
Perbelanjaan pengendalian | 41.27J | 7.10% |
Pendapatan bersih | -103.43J | -110.91% |
Margin untung bersih | -803.05 | -107.59% |
Pendapatan bagi setiap syer | -1.78 | -21.49% |
EBITDA | -115.50J | -13.83% |
Kadar cukai berkesan | — | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 952.86J | -5.17% |
Jumlah aset | 1.39B | -22.66% |
Jumlah liabiliti | 101.38J | -38.61% |
Jumlah ekuiti | 1.28B | — |
Syer tertunggak | 58.31J | — |
Harga kepada buku | 1.24 | — |
Pulangan pada aset | -20.45% | — |
Pulangan pada modal | -21.27% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (USD) | Sep 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | -103.43J | -110.91% |
Tunai daripada operasi | -88.15J | -4.67% |
Tunai daripada pelaburan | 95.56J | -61.90% |
Tunai daripada pembiayaan | 4.44J | 68.18% |
Perubahan bersih dalam tunai | 11.84J | -93.00% |
Aliran tunai bebas | -56.62J | -1,769.96% |
Perihal
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Diasaskan
2008
Tapak web
Pekerja
487
